Gull Laboratories, 1011 E. 4800 South, reported net income of $184,690 or 3 cents per share in the first quarter of 1994, a 200 percent increase over net income of $62,766 or 1 cent per share in the same quarter in 1993.
Milton Adair, president of Gull, a company manufacturing diag-nos-tic test kits for the detection of infectious diseases and autoimmune disorders, said, "I'm encouraged by the trend we see devel-oping and am very gratified by Gull Laboratories' return to profitability."He said that in 1994 Gull's domestic operations should have record sales, spurred by the newly formed direct sales force. "We also anticipate that two of our three European units will become profitable and the third will be moving rapidly toward profitability."